CSL 0.55% $287.92 csl limited

The CEO certainly sounded genuinely excited about the growth...

  1. 2,939 Posts.
    lightbulb Created with Sketch. 165
    The CEO certainly sounded genuinely excited about the growth pipeline in his speech yesterday. Growth in all dimensions: new products(Haegarda & Afstyla), new geographies(China), new supply(collection centres), new volume capacity(plant expansions) , new technologies(Calimmune & Momenta) and future new products progressing through research trial phases(planning for CSL112 phase 3 trial amongst others). All this growth from a business that has consistently maintained ROIC around 25% and with a modest amount of long term fixed debt costing approx 3.3% leading to a ROE between 40 to 50% . This stock should be on a PE closer to 50x
 
watchlist Created with Sketch. Add CSL (ASX) to my watchlist
(20min delay)
Last
$287.92
Change
1.570(0.55%)
Mkt cap ! $139.1B
Open High Low Value Volume
$287.99 $289.76 $286.98 $182.9M 634.7K

Buyers (Bids)

No. Vol. Price($)
1 180 $287.81
 

Sellers (Offers)

Price($) Vol. No.
$288.00 1330 4
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
$288.43
  Change
1.570 ( 0.76 %)
Open High Low Volume
$287.84 $289.73 $286.99 117701
Last updated 15.59pm 28/03/2024 ?
CSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.